Lepu Biopharma Co., Ltd. (Stock Code: 2157) has released a proxy form in preparation for its 2025 second extraordinary general meeting (EGM), scheduled on December 18, 2025, at 10:30 a.m., at Conference Room, Building 7, No. 37 Chaoqian Road, Changping District, Beijing, the PRC.
According to the announcement, the EGM will consider adopting a Restricted Share Unit Scheme (RSU Scheme) and, subject to relevant approvals, implementing a Scheme Mandate Limit. Another resolution will authorize necessary amendments to the Articles of Association to reflect the issuance of new shares under the RSU Scheme. The announcement also specifies instructions for shareholders to appoint proxies, submit relevant documentation before the deadline, and present valid identification for attendance at the EGM.
Comments